CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-14 | Costa Paulo F Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-05-06 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +500 | $0.94 | $470 | 44,968 |
| 2020-05-06 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +7,532 | $1.51 | $11K | 52,500 |
| 2020-05-06 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −500 | $10.00 | $5K | 52,000 |
| 2020-05-06 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −1,000 | $15.00 | $15K | 51,000 |
| 2020-05-06 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −3,000 | $20.00 | $60K | 48,000 |
| 2020-05-06 | Risser Eric Blasius Sr VP & Chief Business Officer | Sale | −3,532 | $25.00 | $88K | 44,468 |
| 2020-05-06 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −500 | $0.94 | $470 | 1,489 |
| 2020-05-06 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −7,532 | $1.51 | $11K | 19,100 |
| 2020-04-16 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +6,000 | $0.94 | $6K | 44,468 |
| 2020-04-16 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −6,000 | $0.94 | $6K | 1,989 |
| 2020-03-13 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +6,000 | $0.94 | $6K | 38,468 |
| 2020-03-13 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −6,000 | $0.94 | $6K | 500 |
| 2020-03-11 | Koenig Scott President and CEO | Exercise or conversion | +133,163 | $0.94 | $125K | 943,103 |
| 2020-03-11 | Koenig Scott President and CEO | Exercise or conversion · Employee stock option (right to buy) | −133,163 | 0 | ||
| 2020-03-06 | Karrels James SVP, CFO and Secretary | Exercise or conversion | +4,473 | $0.94 | $4K | 152,460 |
| 2020-03-06 | Karrels James SVP, CFO and Secretary | Exercise or conversion · Employee stock option (right to buy) | −4,473 | 1,000 | ||
| 2020-02-20 | Bonvini Ezio Sr VP, Research & CSO | Grant or award · Employee stock option (right to buy) | +100,000 | $11.50 | $1.1M | 100,000 |
| 2020-02-20 | Cilinski Lynn VP, Controller and Treasurer | Grant or award · Employee stock option (right to buy) | +35,000 | $11.50 | $403K | 35,000 |
| 2020-02-20 | Karrels James SVP, CFO and Secretary | Grant or award · Employee stock option (right to buy) | +90,000 | $11.50 | $1.0M | 90,000 |
Page 27 of 35 · 684 trades